Table 1 Clinicopathological characteristics and CDC20 expression of 244 patient samples of colorectal cancer
From: CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer
| Â | Number of cases (%) |
|---|---|
Gender | Â |
Male | 158 (64.8) |
Female | 86 (35.2) |
Age (years) | Â |
≤ 50 | 85 (34.8) |
> 50 | 159 (65.2) |
Location | Â |
colon | 113 (46.3) |
rectal | 131 (53.7) |
Clinical stage | Â |
I | 42 (17.2) |
II | 53 (21.7) |
III | 72 (29.5) |
IV | 77 (31.6) |
T classification | Â |
T1 | 16 (6.6) |
T2 | 40 (16.4) |
T3 | 104 (42.6) |
T4 | 84 (34.4) |
N classification | Â |
N0 | 107 (43.9) |
N1 | 75 (30.7) |
N2 | 62 (25.4) |
M classification | Â |
M0 | 167 (68.4) |
M1 | 77 (31.6) |
Pathologic differentiation | Â |
Poor | 55 (22.5) |
Moderate | 168 (68.9) |
Well | 21 (8.6) |
Vital status (at follow-up) | Â |
Alive | 142 (58.2) |
Death (All colorectal cancer-related) | 102 (41.8) |
Expression of CDC20 | Â |
Low expression | 130 (53.3) |
High expression | 114 (46.7) |